Internal Medicine, Rheumatology · Miami, FL
NPI
1871568618
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7190 SW 87th Ave, 304
Miami, FL, 33173
Phone (305) 661-2299
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
69,817 services
Medicare patients, 2024
651
Average age 77
Drug cost, 2024
$2.2M
3,637 prescriptions
Company payments, 2025
$8,351
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Santiago M de Solo was code J0897 (injection, denosumab, 1 mg), 19,022 times for 197 patients. In total Santiago M de Solo billed 69,817 services in 78 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 19,022 | 197 | $20.52 | $390K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 14,089 | 17 | $8.51 | $120K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 4,310 | 11 | $33.72 | $145K |
| J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 3,696 | 40 | $13.66 | $50K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,705 | 160 | $0.74 | $1,266 |
| 99213 Office E&M - Established | Office | 854 | 457 | $72.33 | $62K |
| 96372 Injection Administration | Office | 344 | 186 | $12.58 | $4,328 |
| 99214 Office E&M - Established | Office | 304 | 161 | $99.27 | $30K |
| 20611 Joint Injection | Office | 279 | 111 | $102.26 | $29K |
| 77080 Standard X-ray | Office | 210 | 209 | $43.06 | $9,042 |
| 96413 Chemotherapy Administration | Office | 124 | 23 | $110.33 | $14K |
| 73564 X-ray - Lower Extremity | Office | 101 | 62 | $39.95 | $4,035 |
| 73130 X-ray - Upper Extremity | Office | 90 | 52 | $31.54 | $2,838 |
| J7324 Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | Office | 76 | 11 | $98.41 | $7,479 |
| 73030 X-ray - Upper Extremity | Office | 75 | 48 | $26.36 | $1,977 |
By year: 2022 $1.0M for 62,861 services; 2023 $1.0M for 64,780 services; 2024 $1.1M for 69,817 services.
Medicare prescription drug claims, 2024
In 2024, the drug Santiago M de Solo prescribed most often to Medicare patients was Meloxicam, with 430 prescriptions and refills. In total Santiago M de Solo wrote 3,637 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Meloxicam Generic | 430 | 668 | 122 | $1,871 |
| Prednisone Generic | 265 | 400 | 59 | $1,318 |
| Tramadol Hcl Generic | 259 | 259 | 75 | $1,871 |
| Methotrexate Methotrexate Sodium | 195 | 374 | 48 | $2,665 |
| Tizanidine Hcl Generic | 170 | 245 | 56 | $1,302 |
| Hydroxychloroquine Sulfate Generic | 168 | 390 | 45 | $4,649 |
| Alendronate Sodium Generic | 153 | 386 | 61 | $1,003 |
| Celecoxib Generic | 140 | 231 | 43 | $3,389 |
| Prolia Denosumab | 118 | 705 | 71 | $194K |
| Duloxetine Hcl Generic | 112 | 253 | 31 | $3,670 |
| Diclofenac Sodium Generic | 105 | 124 | 32 | $2,617 |
| Gabapentin Generic | 96 | 164 | 28 | $1,041 |
| Folic Acid Generic | 79 | 199 | 20 | $612 |
| Ibuprofen Generic | 70 | 110 | 28 | $692 |
| Enbrel Sureclick Etanercept | 59 | 59 | Under 11 | $478K |
Brand drugs: - claims; generic drugs: 3,087 claims; opioid claims: 393.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Santiago M de Solo $8,351 ($8,351 in general payments such as food, travel and fees) from 25 companies. The largest payer was Abbvie Inc. with $5,420.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 29 | $5,420 |
| UCB, Inc. UCB.BR | 16 | $368 |
| Mallinckrodt Hospital Products Inc. | 17 | $344 |
| Amgen Inc. AMGN | 30 | $314 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $302 |
| ANI Pharmaceuticals, Inc. ANIP | 9 | $273 |
| Janssen Biotech, Inc. JNJ | 12 | $241 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $152 |
| Sobi, Inc SOBI.ST | 2 | $138 |
| Aurinia Pharma U.S., Inc. AUPH | 5 | $135 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.